Article

HIFU evaluated as second-line treatment for prostate Cancer

Bangkok, Thailand - High-intensity focused ultrasound (HIFU) may serve as an alternative, second-line treatment for prostate cancer patients who are poor candidates for more common primary treatment modalities

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

© 2025 MJH Life Sciences

All rights reserved.